Cargando…
Clinical Course and Outcomes of Severe Covid-19: A National Scale Study
Knowledge of the outcomes of critically ill patients is crucial for health and government officials who are planning how to address local outbreaks. The factors associated with outcomes of critically ill patients with coronavirus disease 2019 (Covid-19) who required treatment in an intensive care un...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408944/ https://www.ncbi.nlm.nih.gov/pubmed/32708357 http://dx.doi.org/10.3390/jcm9072282 |
_version_ | 1783567949601177600 |
---|---|
author | Amit, Moran Sorkin, Alex Chen, Jacob Cohen, Barak Karol, Dana Tsur, Avishai M Lev, Shaul Rozenblat, Tal Dvir, Ayana Landau, Geva Fridrich, Lidar Glassberg, Elon Kesari, Shani Sviri, Sigal Gelman, Ram Miller, Asaf Epstein, Danny Ben-Avi, Ronny Matan, Moshe Jakobson, Daniel J. Bader, Tarif Dahan, David King, Daniel A. Ben-Ari, Anat Soroksky, Arie Bar, Alon Fink, Noam Singer, Pierre Benov, Avi |
author_facet | Amit, Moran Sorkin, Alex Chen, Jacob Cohen, Barak Karol, Dana Tsur, Avishai M Lev, Shaul Rozenblat, Tal Dvir, Ayana Landau, Geva Fridrich, Lidar Glassberg, Elon Kesari, Shani Sviri, Sigal Gelman, Ram Miller, Asaf Epstein, Danny Ben-Avi, Ronny Matan, Moshe Jakobson, Daniel J. Bader, Tarif Dahan, David King, Daniel A. Ben-Ari, Anat Soroksky, Arie Bar, Alon Fink, Noam Singer, Pierre Benov, Avi |
author_sort | Amit, Moran |
collection | PubMed |
description | Knowledge of the outcomes of critically ill patients is crucial for health and government officials who are planning how to address local outbreaks. The factors associated with outcomes of critically ill patients with coronavirus disease 2019 (Covid-19) who required treatment in an intensive care unit (ICU) are yet to be determined. Methods: This was a retrospective registry-based case series of patients with laboratory-confirmed SARS-CoV-2 who were referred for ICU admission and treated in the ICUs of the 13 participating centers in Israel between 5 March and 27 April 2020. Demographic and clinical data including clinical management were collected and subjected to a multivariable analysis; primary outcome was mortality. Results: This study included 156 patients (median age = 72 years (range = 22–97 years)); 69% (108 of 156) were male. Eighty-nine percent (139 of 156) of patients had at least one comorbidity. One hundred three patients (66%) required invasive mechanical ventilation. As of 8 May 2020, the median length of stay in the ICU was 10 days (range = 0–37 days). The overall mortality rate was 56%; a multivariable regression model revealed that increasing age (OR = 1.08 for each year of age, 95%CI = 1.03–1.13), the presence of sepsis (OR = 1.08 for each year of age, 95%CI = 1.03–1.13), and a shorter ICU stay(OR = 0.90 for each day, 95% CI = 0.84–0.96) were independent prognostic factors. Conclusions: In our case series, we found lower mortality rates than those in exhausted health systems. The results of our multivariable model suggest that further evaluation is needed of antiviral and antibacterial agents in the treatment of sepsis and secondary infection. |
format | Online Article Text |
id | pubmed-7408944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74089442020-08-13 Clinical Course and Outcomes of Severe Covid-19: A National Scale Study Amit, Moran Sorkin, Alex Chen, Jacob Cohen, Barak Karol, Dana Tsur, Avishai M Lev, Shaul Rozenblat, Tal Dvir, Ayana Landau, Geva Fridrich, Lidar Glassberg, Elon Kesari, Shani Sviri, Sigal Gelman, Ram Miller, Asaf Epstein, Danny Ben-Avi, Ronny Matan, Moshe Jakobson, Daniel J. Bader, Tarif Dahan, David King, Daniel A. Ben-Ari, Anat Soroksky, Arie Bar, Alon Fink, Noam Singer, Pierre Benov, Avi J Clin Med Article Knowledge of the outcomes of critically ill patients is crucial for health and government officials who are planning how to address local outbreaks. The factors associated with outcomes of critically ill patients with coronavirus disease 2019 (Covid-19) who required treatment in an intensive care unit (ICU) are yet to be determined. Methods: This was a retrospective registry-based case series of patients with laboratory-confirmed SARS-CoV-2 who were referred for ICU admission and treated in the ICUs of the 13 participating centers in Israel between 5 March and 27 April 2020. Demographic and clinical data including clinical management were collected and subjected to a multivariable analysis; primary outcome was mortality. Results: This study included 156 patients (median age = 72 years (range = 22–97 years)); 69% (108 of 156) were male. Eighty-nine percent (139 of 156) of patients had at least one comorbidity. One hundred three patients (66%) required invasive mechanical ventilation. As of 8 May 2020, the median length of stay in the ICU was 10 days (range = 0–37 days). The overall mortality rate was 56%; a multivariable regression model revealed that increasing age (OR = 1.08 for each year of age, 95%CI = 1.03–1.13), the presence of sepsis (OR = 1.08 for each year of age, 95%CI = 1.03–1.13), and a shorter ICU stay(OR = 0.90 for each day, 95% CI = 0.84–0.96) were independent prognostic factors. Conclusions: In our case series, we found lower mortality rates than those in exhausted health systems. The results of our multivariable model suggest that further evaluation is needed of antiviral and antibacterial agents in the treatment of sepsis and secondary infection. MDPI 2020-07-18 /pmc/articles/PMC7408944/ /pubmed/32708357 http://dx.doi.org/10.3390/jcm9072282 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Amit, Moran Sorkin, Alex Chen, Jacob Cohen, Barak Karol, Dana Tsur, Avishai M Lev, Shaul Rozenblat, Tal Dvir, Ayana Landau, Geva Fridrich, Lidar Glassberg, Elon Kesari, Shani Sviri, Sigal Gelman, Ram Miller, Asaf Epstein, Danny Ben-Avi, Ronny Matan, Moshe Jakobson, Daniel J. Bader, Tarif Dahan, David King, Daniel A. Ben-Ari, Anat Soroksky, Arie Bar, Alon Fink, Noam Singer, Pierre Benov, Avi Clinical Course and Outcomes of Severe Covid-19: A National Scale Study |
title | Clinical Course and Outcomes of Severe Covid-19: A National Scale Study |
title_full | Clinical Course and Outcomes of Severe Covid-19: A National Scale Study |
title_fullStr | Clinical Course and Outcomes of Severe Covid-19: A National Scale Study |
title_full_unstemmed | Clinical Course and Outcomes of Severe Covid-19: A National Scale Study |
title_short | Clinical Course and Outcomes of Severe Covid-19: A National Scale Study |
title_sort | clinical course and outcomes of severe covid-19: a national scale study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408944/ https://www.ncbi.nlm.nih.gov/pubmed/32708357 http://dx.doi.org/10.3390/jcm9072282 |
work_keys_str_mv | AT amitmoran clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT sorkinalex clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT chenjacob clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT cohenbarak clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT karoldana clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT tsuravishaim clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT levshaul clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT rozenblattal clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT dvirayana clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT landaugeva clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT fridrichlidar clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT glassbergelon clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT kesarishani clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT svirisigal clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT gelmanram clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT millerasaf clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT epsteindanny clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT benavironny clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT matanmoshe clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT jakobsondanielj clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT badertarif clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT dahandavid clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT kingdaniela clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT benarianat clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT sorokskyarie clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT baralon clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT finknoam clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT singerpierre clinicalcourseandoutcomesofseverecovid19anationalscalestudy AT benovavi clinicalcourseandoutcomesofseverecovid19anationalscalestudy |